What's New

Front Page

Graphic: Volunteer update - hosting an information table event

Volunteer Update: Hosting an Information Table Event

Hosting an information table on behalf of AFTD gives our volunteers a perfect way to bring awareness…

Read More >
Graphic: pilot study evaluates virtual coaching's ability to help FTD care partners with self-care

Pilot Study Evaluates Virtual Coaching’s Ability to Help FTD Care Partners with Self-Care

A pilot study published in the journal Alzheimer’s & Dementia: Translational Research and Clinical Interventions tests if…

Read More >
Graphic: Emma Heming Willis shares insights from her family's FTD journey in essay

Emma Heming Willis Shares Insights from Her Family’s FTD Journey in Essay

In an essay published in Maria Shriver’s Sunday Paper, Emma Heming Willis shared some insights she has…

Read More >
Graphic: Dear HelpLine - Support for Veterans

Dear HelpLine – Support for Veterans

Dear HelpLine, My loved one is a veteran. Do we qualify for any support?  Navigating the Department…

Read More >
Graphic: figure holding large heart over head, AFTD logo in top corner

Provide Help and Bring Hope with a Year-End Gift

AFTD was founded more than 20 years ago with a single donation. Since then, the dedication and…

Read More >
Graphic: AFTD Ambassador shares challenges of being a long-distance care partner in interview

AFTD Ambassador Shares Challenges of Being a Long-Distance Care Partner in Interview

AFTD Ambassador Melissa Fisher shared the realities of being a long-distance care partner in an interview published…

Read More >

FDA Clears Way for Clinical Trial for AviadoBio Therapy That Could Halt FTD Progression

AviadoBio will soon open U.S. clinical trial sites for an experimental gene therapy that could halt the…

Read More >
AFTD Logo

AFTD Update: Updated Digital Resources for FTD & Genetics 

The FTD & Genetics section of AFTD’s website has been newly updated to help families better understand…

Read More >
Graphic: landmark trial evaluating potential FTD-GRN therapeutic completes enrollment

Landmark Trial Evaluating Potential FTD-GRN Therapeutic Completes Enrollment

Biotechnology company Alector Therapeutics announced on October 27 that it has completed enrollment for INFRONT-3, a Phase…

Read More >
Graphic: The Lived Experience of FTD: Anosognosia

The Lived Experience of FTD: Anosognosia

The following article was written by Kevin Rhodes, a member of AFTD’s Persons with FTD Advisory Council….

Read More >